News

A new online registry launched by Cedars-Sinai Medical Center, the non-profit hospital and academic health science institution in Los Angeles, US, is looking to boost women’s participation in oncology clinical research.

The European Parliament’s Committee on Environment and Public Health has unanimously adopted rapporteur Glenis Willmott’s amendments to the Commission’s proposed regulation on clinical trials, including provisions requiring sponsors to publish full Clinical Study Reports once a marketing-authorisation decision has been taken.

A new alliance of 10 leading life-science institutes aims to raise the international profile of European research and develop co-ordinated responses to the challenges facing the sector.

A study of five European Union (EU) nations finds that Germany provides the most favourable environment for biosimilar drugs, while Italy is the least favourable.

Amgen and Astellas have announced a unique long-term collaboration that will see the firms work together on new treatments and geographies.

AstraZeneca will pay a maximum of $443 million for lipid lowering specialist Omthera Pharma to gain access to its anti-triglyceride drug Epanova.

Legislation to enable the introduction of reference pricing and pro-generic initiatives has now been passed by both houses of Ireland’s parliament (Oireachtas) and is expected to take effect next month.

Under its expanded health and social care remit, NICE has released new advice to GPs and practice nurses to help them identify adults who are not active enough and to encourage them to get moving.

The UK’s Department of Health has injected an extra £4 million into the NHS to improve the way diseases are diagnosed.

The sales representatives that give the most value to doctors cover psychiatry, oncology, paediatrics and ophthalmology, results from an exclusive poll for PharmaTimes show.

India has announced plans for a new short-term strategy aimed at boosting pharmaceutical exports, and has also set guidelines for domestic drugmakers to comply with a European Union (EU) directive on imports of bulk drugs into Europe.

Cost regulators for the National Health Service in England and Wales have issued final guidance recommending Novartis’ Lucentis as a treatment for a common eye condition called macular oedema.

Twice as many patients with non-Hodgkin’s lymphoma (NHL) are hitting a post-diagnosis survival marker than in the 1970’s, a report by Cancer Research and the Haematological Malignancy Research Network has found.  

Pharma spending on US doctors topped $1 billion last year as the industry braces for the arrival of the Sunshine Act.

Around 20% of clinical trials currently underway are using adaptive designs, while adoption of these techniques is likely to increase significantly over the next few years, particularly in the exploratory phase of drug development, a new report suggests.